A man may see a high number on his prostate blood test and jump straight to the possibility of cancer. But PSA, or prostate-specific antigen, is not a diagnosis on its own. It is one part of an assessment that brings together your age, family history, examination, prostate size and how the result changes over time. Understanding this bigger picture helps avoid hasty decisions and unnecessary worry.
Why the result may be raised
PSA is a protein made by the prostate, and its level can rise with benign enlargement, inflammation or urinary retention, as well as with cancer. Temporary factors or recent procedures can also affect the reading. Some medicines for an enlarged prostate lower the PSA value, so your doctor needs to know if you take them to interpret the result correctly.
Do I need a biopsy straight away?
Not always. The test may be repeated in suitable circumstances, especially when the rise is small and there are no other worrying signs. Your doctor will also consider possible inflammation, the clinical examination, and PSA density, which relates the PSA to the size of the gland. Giving antibiotics just to bring the number down, without evidence of infection, is no substitute for a structured assessment.
The role of MRI
MRI has become an important step before biopsy when localised cancer is suspected. It helps identify areas that need targeted samples, and the result is interpreted using the PI-RADS scoring system together with your other risk factors. A low-suspicion MRI doesn't completely rule out cancer, and a biopsy or close monitoring may still be needed depending on your case.
Many centres use transperineal biopsies, taken through the skin between the scrotum and anus, which carry a lower risk of infection than the transrectal route, with the samples chosen according to your doctor's plan.
If cancer is found
Not all prostate cancers behave the same way. The grade, stage, amount of tumour and your general health decide the treatment plan. Active surveillance may suit some low-risk cases, while others need surgery, radiotherapy or additional treatments.
The decision to have regular PSA testing in the first place also deserves a discussion about the expected benefit and the chance of finding slow-growing tumours. The goal is to detect clinically significant disease, then choose treatment that matches how serious it is and fits the patient's life.
This article is general health education and doesn't replace a consultation with your doctor.
